A large nosocomial outbreak of hepatitis C and hepatitis B among patients receiving pain remediation treatments

Infection Control and Hospital Epidemiology

Volumn 25, Issue 7, 2004, Pages 576-583

  Comstock, R Dawn ^a,b   Mallonee, Sue ^a   Fox, Jan L ^a   Moolenaar, Ronald L ^b   Vogt, Tara M ^c   Perz, Joseph F ^c   Bell, Beth P ^c   Crutcher, James M ^a  

^a OKLAHOMA STATE DEPARTMENT OF HEALTH   (United States)

^b Epidemiology and Analysis Program Office   (United States)

^c NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SEDATIVE AGENT;

ADOLESCENT; ADULT; AGED; EPIDEMIC; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS C; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INFECTION RATE; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NEEDLE; NONHUMAN; NURSE; PAIN CLINIC; REVIEW; RISK FACTOR; SEDATION; SEROLOGY; STAFF TRAINING; SYRINGE; VIRUS TRANSMISSION;

EID: 3242736818     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/502442     Document Type: Review

References (41)

1. Heseltine P. Anesthesiologists should not give IV medications with a common syringe. Hosp Infect Control 1986;13:84-85.
2. Kempen PM. Contamination of syringes. Can J Anaesth 1989;36:730-731.
3. Expanded Programme on Immunization. Changing needles but not the syringe: an unsafe practice. World Health Organization Weekly Epidemiological Record 1987;62:345-346.
4. Lutz CT, Bell CE Jr, Wedner HJ, Krogstad DJ. Allergy testing of multiple patients should no longer be performed with a common syringe. N Engl J Med 1984;310:1335-1337.
5. Monti EJ. The safe use of disposable syringes in anesthesia: cost effective or costly? CRNA: The Clinical Forum for Nurse Anesthetists 1995;6:86-90.
6. Trepanier CA, Lessard MR, Brochu JG, Denault PH. Risk of cross-infection related to the multiple use of disposable syringes. Can J Anaesth 1990;37:156-159.
7. Fleming A, Ogilvie AC. Syringe needles and mass inoculation technique. Br Med J 1951;1:543-546.
8. Knoll A, Helmig M, Peters O, Jilg W. Hepatitis C virus transmission in a pediatric oncology ward: analysis of an outbreak and review of the literature. Lab Invest 2001;81:251-262.
9. Allander T, Gruber A, Naghavi M, et al. Frequent patient-to-patient transmission of hepatitis C virus in a haematology ward. Lancet 1995;345:603-607.
10. Bruguera M, Saiz JC, Franco S, et al. Outbreak of nosocomial hepatitis C virus infection resolved by genetic analysis of HCV RNA. J Clin Microbiol 2002;40:4363-4366.
11. Krause G, Trepka MJ, Whisenhunt RS, et al. Nosocomial transmission of hepatitis C virus associated with the use of multidose saline vials. Infect Control Hosp Epidemiol 2003;24:122-127.
12. Widell A, Christensson B, Wiebe T, et al. Epidemiologic and molecular investigation of outbreaks of hepatitis C virus infection on a pediatric oncology service. Ann Intern Med 1999;130:130-134.
13. Canter J, Mackey K, Good LS, et al. An outbreak of hepatitis B associated with jet injections in a weight reduction clinic. Arch Intern Med 1990;150:1923-1927.
14. Hlady WG, Hopkins RS, Ogilby TE, Allen, ST. Patient-to-patient transmission of hepatitis B in a dermatology practice. Am J Public Health 1993;83:1689-1693.
15. Kent GP, Brondum J, Keenlyside RA, LaFazia LM, Scott HD. A large outbreak of acupuncture associated hepatitis B. Am J Epidemiol 1988;127:591-598.
16. Polish LB, Shapiro CN, Bauer F, et al. Nosocomial transmission of hepatitis B virus associated with the use of a spring-loaded finger-stick device. N Engl J Med 1992;326:721-725.
17. Quale JM, Landman D, Wallace B, Atwood E, Ditore V, Fruchter G. Déjà vu: nosocomial hepatitis B virus transmission and fingerstick monitoring. Am J Med 1998;105:296-301.
18. Centers for Disease Control and Prevention. Transmission of hepatitis B and C viruses in outpatient settings: New York, Oklahoma, and Nebraska, 2000-2002. MMWR 2003;52:901-908.
19. Fleiss J. Statistical Methods for Rates and Proportions, ed. 2. Hoboken, NJ: Wiley; 1981.
20. Schlesselman JJ. Case-Control Studies. New York: Oxford University Press; 1982:203-206.
21. Druce JD, Catton MG, Ryan G, Birch CJ. Survival of a hepatitis C virus surrogate in anaesthetic and analgesic drugs. Australian Infection Control 2001;6:89-90.
22. Bennet SN, McNeil MM, Bland LA, et al. Postoperative infections traced to contamination of an intravenous anesthetic, propofol. N Engl J Med 1995;333:147-154.
23. Cody SH, Nainan OV, Garfein RS, et al. Hepatitis C virus transmission from an anesthesiologist to a patient. Arch Intern Med 2002;162:345-350.
24. Ross RS, Viazov S, Gross T, Hofmann F, Seipp H, Roggendorf M. Transmission of hepatitis C virus from a patient to an anesthesiology assistant to five patients. N Engl J Med 2000;343:1851-1854.
25. Tait AR, Tuttle DB. Preventing perioperative transmission of infection: a survey of anesthesiology practice. Anesth Analg 1995;80:764-769.
26. Rosenberg AD, Bernstein DB, Bernstein RL, Skovron ML, Ramanathan S, Turndorf S. Accidental needlesticks: do anesthesiologists practice proper infection control precautions? Am J Anesthesiol 1995;22:125-132.
27. Greene ES. Hepatitis C outbreak: more than 50 infected by reused needles and syringes. American Society of Anesthesiologists Newsletter 2002;66:22-23.
28. Bosch X. Newspaper apportions blame in Spanish hepatitis C scandal. Lancet 2000;355:818.
29. American Association of Nurse Anesthetists. Reuse of Needles and Syringes by Healthcare Providers Puts Patients at Risk [press release]. Park Ridge, IL: American Association of Nurse Anesthetists; 2002. Available at www.aana.com/press/2002/111302.asp. Accessed March 31, 2004.
30. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001;345:41-52.
31. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999;341:556-562.
32. Goldstein ST, Alter MJ, Williams IT, et al. Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: implications for vaccination programs. J Infect Dis 2002;185:713-719.
33. Alter MJ. Prevention of spread of hepatitis C. Hepatology 2002;36(5 suppl 1):S93-S98.
34. Aylward B, Kane M, McNair-Scott R, Hu DJ. Model-based estimates of the risk of human immunodeficiency virus and hepatitis B virus transmission through unsafe injections. Int J Epidemiol 1995;24:446-452.
35. Hutin YJF, Harpaz R, Drobeniuc J, et al. Injections given in healthcare settings as a major source of acute hepatitis B in Moldova. Int J Epidemiol 1999;28:782-786.
36. Abdul MS, Adill MM, Altaf A, Hutin Y, Luby S. Recycling of injection equipment in Pakistan. Infect Control Hosp Epidemiol 2003;23:145-146.
37. Abulrahi HA, Bohlega EA, Fontaine RE, al-Seghayer SM, al-Ruwais AA. Plasmodium falciparum malaria transmitted in a hospital through heparin locks. Lancet 1997;349:23-25.
38. Allander T, Medin C, Jacobson SH, Grillner L, Persson MA. Hepatitis C transmission in a hemodialysis unit: molecular evidence for spread of virus among patients not sharing equipment. J Med Virol 1994;43:415-419.
39. Lark B, Hu YW, Krajden M, et al. Acute nosocomial HCV infection detected by NAT of a regular blood donor. Transfusion 2002;42:759-765.
40. Sanchez-Tapias JM. Nosocomial transmission of hepatitis C virus. J Hepatol 1999;31(suppl 1):107-112.
41. Massari M, Petrosillo N, Ippolito G, et al. Transmission of hepatitis C virus in a gynecological surgery setting. J Clin Microbiol 2001;39:2860-2863.